UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Guidelines for the welfare and use of animals in cancer research

British journal of cancer, 2010-05, Vol.102 (11), p.1555-1577

2010

Volltextzugriff (PDF)

ZD6474 - a novel inhibitor of VEGFR and EGFR tyrosine kinase activity

British journal of cancer, 2005-06, Vol.92 (S1), p.S6-S13

2005

Volltextzugriff (PDF)

Surface Plasmon Mediated Emission from Organic Light-Emitting Diodes

Advanced materials (Weinheim), 2002-10, Vol.14 (19), p.1393-1396

2002

Volltextzugriff (PDF)

A study into the impact of interface roughness development on mechanical degradation of oxides formed on zirconium alloys

Journal of nuclear materials, 2015-04, Vol.459, p.166-174

2015

Volltextzugriff (PDF)

ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model

British journal of cancer, 2002-04, Vol.86 (7), p.1157-1161

2002

Volltextzugriff (PDF)

A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer

Critical reviews in oncology/hematology, 2017-04, Vol.112, p.80-102

2017

Volltextzugriff (PDF)

Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours

British journal of cancer, 2003-11, Vol.89 (10), p.1889-1895

2003

Volltextzugriff (PDF)

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

Cancer treatment reviews, 1997, Vol.23 (1), p.35-61

1997

Volltextzugriff (PDF)

Surface plasmon-polariton mediated emission from phosphorescent dendrimer light-emitting diodes

Applied physics letters, 2006-04, Vol.88 (16), p.161105-161105-3

2006

Volltextzugriff (PDF)

ZD4190 : An orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy

Cancer research (Chicago, Ill.), 2000-02, Vol.60 (4), p.970-975

2000

Volltextzugriff (PDF)

Surface plasmon–polariton mediated emission of light from top-emitting organic light-emitting diode type structures

Organic electronics, 2007-04, Vol.8 (2-3), p.136-147

2007

Volltextzugriff (PDF)

Can lasing at visible wavelengths be achieved using the low-loss long-range surface plasmon-polariton mode?

New journal of physics, 2006-08, Vol.8 (8), p.125-125

2006

Volltextzugriff (PDF)

298: Induction of HIF1a influences estrogen receptor expression in ex-vivo culture of tumour tissue

European journal of cancer (1990), 2014-07, Vol.50, p.S70-S71

2014

Volltextzugriff (PDF)

Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media

Magnetic resonance imaging, 2003-10, Vol.21 (8), p.845-851

2003

Volltextzugriff (PDF)

Design and Structure−Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors

Journal of medicinal chemistry, 1999-12, Vol.42 (26), p.5369-5389

1999

Volltextzugriff (PDF)

Phase I trial of temozolomide using an extended continuous oral schedule

Cancer research (Chicago, Ill.), 1998-10, Vol.58 (19), p.4363-4367

1998

Volltextzugriff (PDF)

325 Identification and characterization of an irreversible inhibitor of CDK2

European journal of cancer (1990), 2014-11, Vol.50, p.106-106

2014

Volltextzugriff (PDF)

Inhibition of vascular endothelial growth factor signalling using cediranib (RECENTIN; AZD2171) enhances radiation response and causes substantial physiological changes in lung tumour xenografts

British journal of radiology, 2008-10, Vol.81 Spec No 1 (special_issue_1), p.S21-S27

2008

Volltextzugriff (PDF)

The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma

Angiogenesis (London), 2004-12, Vol.7 (4), p.347-354

2004

Volltextzugriff (PDF)

Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol)

NMR in biomedicine, 2008-01, Vol.21 (1), p.42-52

2008

Volltextzugriff (PDF)

Spontaneous emission from within a metal-clad cavity mediated by coupled surface plasmon–polaritons

Journal of physics. Condensed matter, 2008-07, Vol.20 (30), p.304218-304218 (6)

2008

Volltextzugriff (PDF)

ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity

Microcirculation (New York, N.Y. 1994), 2002-12, Vol.9 (6), p.513-522

2002

Volltextzugriff (PDF)

Wave techniques for noise modeling and measurement

IEEE transactions on microwave theory and techniques, 1992-11, Vol.40 (11), p.2004-2012

1992

Volltextzugriff (PDF)

289 (PB277): Pulsatile induction of the p53 pathway by MDM2 antagonist ASTX295 shows an enhanced therapeutic index in vivo

European journal of cancer (1990), 2024-10, Vol.211, p.114804, Article 114804

2024

Volltextzugriff (PDF)

Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro

British journal of cancer, 1996-02, Vol.73 (4), p.482-490

1996

Volltextzugriff (PDF)

1 – 25 von 1.332

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.007)
Mit Volltextzugriff
(913)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(607)
Life Sciences & Biomedicine
(457)
Humans
(318)
Physical Sciences
(151)
Biological And Medical Sciences
(139)
Female
(122)
Male
(121)
Animals
(116)
Chemistry
(114)
Medical Sciences
(89)
Mutation
(79)
Pharmacology & Pharmacy
(79)
Agriculture
(77)
Oncology
(72)
Tumors
(70)
Biochemistry & Molecular Biology
(68)
Technology
(68)
Fundamental And Applied Biological Sciences. Psychology
(58)
Mice
(58)
Cancer
(57)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(7)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Guidelines for the welfare and use of animals in cancer research

ZD6474 - a novel inhibitor of VEGFR and EGFR tyrosine kinase activity

Surface Plasmon Mediated Emission from Organic Light-Emitting Diodes

A study into the impact of interface roughness development on mechanical degradation of oxides formed on zirconium alloys

ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model

A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer

Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

Surface plasmon-polariton mediated emission from phosphorescent dendrimer light-emitting diodes

ZD4190 : An orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy

Surface plasmon–polariton mediated emission of light from top-emitting organic light-emitting diode type structures

Can lasing at visible wavelengths be achieved using the low-loss long-range surface plasmon-polariton mode?

298: Induction of HIF1a influences estrogen receptor expression in ex-vivo culture of tumour tissue

Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media

Design and Structure−Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors

Phase I trial of temozolomide using an extended continuous oral schedule

325 Identification and characterization of an irreversible inhibitor of CDK2

Inhibition of vascular endothelial growth factor signalling using cediranib (RECENTIN; AZD2171) enhances radiation response and causes substantial physiological changes in lung tumour xenografts

The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma

Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol)

Spontaneous emission from within a metal-clad cavity mediated by coupled surface plasmon–polaritons

ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity

Wave techniques for noise modeling and measurement

289 (PB277): Pulsatile induction of the p53 pathway by MDM2 antagonist ASTX295 shows an enhanced therapeutic index in vivo

Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro

Suchergebnisse filtern